Catherine Pearce serves as Executive at CinCor Pharma, Inc., where they oversee executive responsibilities. Since joining the company, Catherine Pearce has executed 8 insider transactions totaling $36.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 24, 2023 involved selling 15,000 shares valued at $0.
Catherine Pearce currently holds 15,000 shares of CinCor Pharma, Inc. (CINC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Catherine Pearce has been a net buyer of CINC stock. They have purchased $36.0K and sold $0 worth of shares.
Catherine Pearce's most recent insider trade was on Feb 24, 2023, when they sold 15,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Feb 24, 2023 | CINC | $0 | Tender | 1,500 | $N/A | Discretionary |
| Jan 26, 2023 | CINC | $0 | Award | 15,000 | $N/A | Discretionary |
| Jan 11, 2023 | CINC | $0 | Option Exercise | 13,235 | $N/A | Discretionary |
| Jan 11, 2023 | CINC | $114.9K | Payment | 3,997 | $28.75 | Discretionary |
| Jan 11, 2022 | CINC | $12.0K | Purchase | 750 | $16.00 | Discretionary |
| Jan 11, 2022 | CINC | $24.0K | Purchase | 1,500 | $16.00 | Discretionary |